Patients should report persistent injection site changes, unexplained neck masses, severe gastrointestinal symptoms, or signs of pancreatitis promptly for appropriate clinical assessment and management
The future directions and challenges of new small-molecule GLP-1R agonists, such as danuglipron, are multifaceted
Research on GLP-1 receptor agonists shows that losing 10 to 15% of body weight can reduce the Apnea-Hypopnea Index (AHI) by 30 to 50%
Always follow the manufacturer's guidelines and consult a healthcare provider for personalized recommendations
Todays mass use of GLP-1s has opened the door for scientists to explore other potential treatment uses for the drug, including for addiction, Alzheimers and liver, kidney and autoimmune disease
You should inject semaglutide once a week on the same day of the week, every week